{"AllianceGenome": "10451", "HGNC": "10451", "MIM": "180410", "_id": "6240", "_version": 1, "accession": {"genomic": ["AC015689.12", "AF107045.1", "AF391285.1", "CH471158.1", "CP068267.2", "L10342.1", "NC_000011.10", "NC_060935.1", "NG_027992.2", "X65708.1"], "protein": ["AAD37491.1", "AAH06498.1", "BAD96506.1", "BAG60296.1", "BAG61557.1", "BAG63322.1", "BAG63343.1", "BAG64450.1", "CAA42118.1", "CAA42180.1", "EAX02583.1", "NP_001024.1", "NP_001304993.1", "NP_001304994.1", "NP_001317122.1", "P23921.1"], "rna": ["AK222786.1", "AK297988.1", "AK299629.1", "AK301891.1", "AK301922.1", "AK303394.1", "AK307950.1", "AK311593.1", "BC006498.2", "BF681281.1", "BM464333.1", "BP229960.1", "BQ775841.1", "CB853003.1", "NM_001033.5", "NM_001318064.1", "NM_001318065.1", "NM_001330193.1", "X59543.1", "X59617.1"], "translation": [{"protein": "AAH06498.1", "rna": "BC006498.2"}, {"protein": "CAA42180.1", "rna": "X59617.1"}, {"protein": "NP_001024.1", "rna": "NM_001033.5"}, {"protein": "BAG64450.1", "rna": "AK303394.1"}, {"protein": "NP_001304993.1", "rna": "NM_001318064.1"}, {"protein": "NP_001317122.1", "rna": "NM_001330193.1"}, {"protein": "BAG60296.1", "rna": "AK297988.1"}, {"protein": "BAG61557.1", "rna": "AK299629.1"}, {"protein": "BAD96506.1", "rna": "AK222786.1"}, {"protein": "CAA42118.1", "rna": "X59543.1"}, {"protein": "BAG63343.1", "rna": "AK301922.1"}, {"protein": "BAG63322.1", "rna": "AK301891.1"}, {"protein": "NP_001304994.1", "rna": "NM_001318065.1"}]}, "alias": ["PEOB6", "R1", "RIR1", "RR1"], "ec": "1.17.4.1", "ensembl": {"gene": "ENSG00000167325", "protein": ["ENSP00000300738", "ENSP00000431464", "ENSP00000432555", "ENSP00000434069", "ENSP00000435656", "ENSP00000436377"], "transcript": ["ENST00000300738", "ENST00000526304", "ENST00000526350", "ENST00000526865", "ENST00000528442", "ENST00000528470", "ENST00000529109", "ENST00000530368", "ENST00000531591", "ENST00000532170", "ENST00000532710", "ENST00000533349", "ENST00000533495", "ENST00000534285"], "translation": [{"protein": "ENSP00000435656", "rna": "ENST00000532170"}, {"protein": "ENSP00000300738", "rna": "ENST00000300738"}, {"protein": "ENSP00000434069", "rna": "ENST00000533349"}, {"protein": "ENSP00000432555", "rna": "ENST00000528442"}, {"protein": "ENSP00000431464", "rna": "ENST00000534285"}, {"protein": "ENSP00000436377", "rna": "ENST00000533495"}], "type_of_gene": "protein_coding"}, "entrezgene": "6240", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 33.8057476441, "exp_mis": 240.825847402, "exp_syn": 93.8175311123, "lof_z": 5.75950262571473, "mis_z": 3.80824288600877, "mu_lof": 2.42184095011e-06, "mu_mis": 2.12582018174e-05, "mu_syn": 7.87886426321e-06, "n_lof": 0.0, "n_mis": 120.0, "n_syn": 99.0, "p_li": 0.999994803572266, "p_null": 2.88252150802573e-14, "p_rec": 5.19642770538439e-06, "syn_z": -0.331699092235328}, "bp": 2379, "cds_end": 4159613, "cds_start": 4116242, "n_exons": 19, "nonpsych": {"exp_lof": 30.2255800597, "exp_mis": 217.598753239, "exp_syn": 84.5420377673, "lof_z": 5.39932280721052, "mis_z": 3.64490086702418, "mu_lof": 2.42184095011e-06, "mu_mis": 2.12582018174e-05, "mu_syn": 7.87886426321e-06, "n_lof": 0.0, "n_mis": 111.0, "n_syn": 85.0, "p_li": 0.999982690563968, "p_null": 6.58969786059557e-13, "p_rec": 1.73094353734963e-05, "syn_z": -0.0313584542487792}, "nontcga": {"exp_lof": 31.0650400634, "exp_mis": 221.523546332, "exp_syn": 86.2758859775, "lof_z": 5.49815789896051, "mis_z": 3.90043959963628, "mu_lof": 2.42184095011e-06, "mu_mis": 2.12582018174e-05, "mu_syn": 7.87886426321e-06, "n_lof": 0.0, "n_mis": 105.0, "n_syn": 93.0, "p_li": 0.999986095249597, "p_null": 3.16316140015773e-13, "p_rec": 1.39047500861073e-05, "syn_z": -0.458365994421707}, "transcript": "ENST00000300738.5"}, "exons": [{"cdsend": 4138383, "cdsstart": 4095012, "chr": "11", "position": [[4094798, 4095031], [4101992, 4102081], [4106045, 4106223], [4107434, 4107535], [4109643, 4109703], [4111600, 4111640], [4111899, 4112062], [4118319, 4118461], [4119844, 4119928], [4121603, 4121765], [4122140, 4122220], [4123182, 4123384], [4126683, 4126833], [4127034, 4127256], [4129073, 4129150], [4132285, 4132421], [4133562, 4133658], [4135081, 4135270], [4138194, 4138932]], "strand": 1, "transcript": "NM_001033", "txend": 4138932, "txstart": 4094798}, {"cdsend": 4138383, "cdsstart": 4107439, "chr": "11", "position": [[4094684, 4095031], [4101992, 4102081], [4107434, 4107535], [4109643, 4109703], [4111600, 4111640], [4111899, 4112062], [4118319, 4118461], [4119844, 4119928], [4121603, 4121765], [4122140, 4122220], [4123182, 4123384], [4126683, 4126833], [4127034, 4127256], [4129073, 4129150], [4132285, 4132421], [4133562, 4133658], [4135081, 4135270], [4138194, 4138925]], "strand": 1, "transcript": "NM_001318064", "txend": 4138925, "txstart": 4094684}, {"cdsend": 4138383, "cdsstart": 4121741, "chr": "11", "position": [[4116077, 4116360], [4118319, 4118461], [4119844, 4119970], [4121603, 4121765], [4122140, 4122220], [4123182, 4123384], [4126683, 4126833], [4127034, 4127256], [4129073, 4129150], [4132285, 4132421], [4133562, 4133658], [4135081, 4135270], [4138194, 4138925]], "strand": 1, "transcript": "NM_001318065", "txend": 4138925, "txstart": 4116077}, {"cdsend": 4138383, "cdsstart": 4118335, "chr": "11", "position": [[4116077, 4116360], [4118319, 4118461], [4119844, 4119928], [4121603, 4121765], [4122140, 4122220], [4123182, 4123384], [4126683, 4126833], [4127034, 4127256], [4129073, 4129150], [4132285, 4132421], [4133562, 4133658], [4135081, 4135270], [4138194, 4138925]], "strand": 1, "transcript": "NM_001330193", "txend": 4138925, "txstart": 4116077}], "exons_hg19": [{"cdsend": 4159613, "cdsstart": 4116242, "chr": "11", "position": [[4116028, 4116261], [4123222, 4123311], [4127275, 4127453], [4128664, 4128765], [4130873, 4130933], [4132830, 4132870], [4133129, 4133292], [4139549, 4139691], [4141074, 4141158], [4142833, 4142995], [4143370, 4143450], [4144412, 4144614], [4147913, 4148063], [4148264, 4148486], [4150303, 4150380], [4153515, 4153651], [4154792, 4154888], [4156311, 4156500], [4159424, 4160162]], "strand": 1, "transcript": "NM_001033", "txend": 4160162, "txstart": 4116028}, {"cdsend": 4159613, "cdsstart": 4128669, "chr": "11", "position": [[4115914, 4116261], [4123222, 4123311], [4128664, 4128765], [4130873, 4130933], [4132830, 4132870], [4133129, 4133292], [4139549, 4139691], [4141074, 4141158], [4142833, 4142995], [4143370, 4143450], [4144412, 4144614], [4147913, 4148063], [4148264, 4148486], [4150303, 4150380], [4153515, 4153651], [4154792, 4154888], [4156311, 4156500], [4159424, 4160155]], "strand": 1, "transcript": "NM_001318064", "txend": 4160155, "txstart": 4115914}, {"cdsend": 4159613, "cdsstart": 4142971, "chr": "11", "position": [[4137307, 4137590], [4139549, 4139691], [4141074, 4141200], [4142833, 4142995], [4143370, 4143450], [4144412, 4144614], [4147913, 4148063], [4148264, 4148486], [4150303, 4150380], [4153515, 4153651], [4154792, 4154888], [4156311, 4156500], [4159424, 4160155]], "strand": 1, "transcript": "NM_001318065", "txend": 4160155, "txstart": 4137307}, {"cdsend": 4159613, "cdsstart": 4139565, "chr": "11", "position": [[4137307, 4137590], [4139549, 4139691], [4141074, 4141158], [4142833, 4142995], [4143370, 4143450], [4144412, 4144614], [4147913, 4148063], [4148264, 4148486], [4150303, 4150380], [4153515, 4153651], [4154792, 4154888], [4156311, 4156500], [4159424, 4160155]], "strand": 1, "transcript": "NM_001330193", "txend": 4160155, "txstart": 4137307}], "generif": [{"pubmed": 12687015, "text": "overexpression of RRM1 in human and mouse lung cancer cell lines induced PTEN expression, reduced phosphorylation of focal adhesion kinase (FAK), suppressed migration, invasion, and metastasis formation, and increased survival in an animal model."}, {"pubmed": 12789263, "text": "RRM1 levels influenced time to progression (P=0.05) and even more so, survival (P=0.0028) in the gemcitabine/cisplatin arm"}, {"pubmed": 14729598, "text": "Susceptibility differences to RR inhibitors between hRRM1 and hRRM2 may lead to a new direction in drug design for human cancer treatment."}, {"pubmed": 15172981, "text": "The level of RRM1 may affect gemcitabine response in non-small cell lung cancer. Furthermore, RRM1 may serve as a biomarker for gemcitabine response."}, {"pubmed": 15277258, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16376858, "text": "the binding site on RRM1 demonstrated higher affinity for RRM2 subunit than for p53R2 subunit"}, {"pubmed": 16476973, "text": "overexpressed during the S phase of the cell cycle compared with the G0/1 phase"}, {"pubmed": 16481328, "text": "Motexafin gadolinium induces enzymatic generation of reactive oxygen species by thioredoxin reductase and inhibits ribonucleotide reductase"}, {"pubmed": 16966686, "text": "results strongly suggest that tumoral RRM1 expression is a major predictor of disease response to gemcitabine/platinum chemotherapy"}, {"pubmed": 17064812, "text": "RRM1 could play a role in the prediction of patient outcome, and draw attention to the fact that response to gemcitabine."}, {"pubmed": 17065054, "text": "RRM1 RNA expression has a role in acquired resistance to gemcitabine"}, {"pubmed": 17131328, "text": "RRM1 should be a key molecule in gemcitabine resistance in human pancreatic cancer."}, {"pubmed": 17602053, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17602053, "text": "RRM1 haplotype showed an association with susceptibility to gemcitabine monotherapy in breast cancer patients."}, {"pubmed": 18414411, "text": "Ribonucleotide reductase subunit M1(RRM1) mRNA expression in lung adenocarcinoma is associated with clinical outcome of docetaxel/gemcitabine therapy."}, {"pubmed": 18483375, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18483375, "text": "significant differences in response rates to gemcitabine-based chemotherapy according to the allelotypes of the RRM1 promoter sequence"}, {"pubmed": 18494946, "text": "Significantly higher RRM1 mRNA expression was found in SCLC compared with NSCLC.  There was no correlation between mRNA expression of the RRM1 gene and chemosensitivity to cisplatin, carboplatin or gemcitabine."}, {"pubmed": 18636187, "text": "Expression of RRM1 is associated with chemoresistance marker to gemcitabine in biliary tract carcinoma"}, {"pubmed": 19002265, "text": "The mRNA expression of RRM1 is potentially a useful tool for selecting NSCLC patients for individualized chemotherapy"}, {"pubmed": 19304340, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19304340, "text": "genetic polymorphisms is associated with sensitivity to platin-based chemotherapy in non-small cell lung cancer patients"}, {"pubmed": 19543324, "text": "Data show that the combination of RRM1 and ERCC1 expression is prognostic in pancreatic cancer patients after a complete resection."}, {"pubmed": 19552012, "text": "patients with advanced NSCLC treated with chemotherapy with gemcitabine and cisplatin appear to have a poor outcome if the tumor express elevated levels of RRM1 gene but surgical resection shows better survival."}, {"pubmed": 20021860, "text": "Esophageal squamous cell carcinoma cells with a lower level of RRM1 expression are more sensitive to gemcitabine."}, {"pubmed": 20028759, "text": "Clinical trial of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20043067, "text": "RRM1 suppression is an important step in increasing Gemcitabine efficacy"}, {"pubmed": 20159953, "text": "Tip60-dependent recruitment of RNR plays an essential role in dNTP supply for DNA repair"}, {"pubmed": 20211060, "text": "Compared with their parental cells, the expressions of CDA, RRM1, PTEN and ERCC1 increase in human gemcitabine-resistant non-small cell lung cancer cell lines."}, {"pubmed": 20226083, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20226083, "text": "RRM1 single nucleotide polymorphism is not associated with non-small cell lung cancer patients after gemcitabine-based chemotherapy."}, {"pubmed": 20453000, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20467918, "text": "ERCC1, RRM1 and BRCA1 are promising predictive and prognostic biomarkers in advanced non-small cell lung cancer."}, {"pubmed": 20587610, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20627363, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20811706, "text": "RRM1, particularly in protein, level is a reliable marker for gemcitabine resistance in biliary tract carcinoma."}, {"pubmed": 20819778, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20868593, "text": "In postoperative NSCLC patients who are receiving adjuvant chemotherapy, patients with high expression of RRM1 tend to be resistant to gemcitabine."}, {"pubmed": 21220199, "text": "RRM1 -37A>C polymorphism may represent a useful biomarker to select mCRC patients most likely to benefit from gemcitabine-based salvage therapy."}, {"pubmed": 21264835, "text": "M1 (RRM1) expression in resected pancreatic cancer is not associated with OS or Pfs."}, {"pubmed": 21336276, "text": "The study reports the first X-ray structures of human RR1 bound to TTP alone, dATP alone, TTP-GDP, TTP-ATP, and TTP-dATP."}, {"pubmed": 21370501, "text": "RRM1 has a role in response to gemcitabine plus platinum therapy in advanced non-small-cell lung cancer"}, {"pubmed": 21394302, "text": "Cases with EGFR overexpression showed high expression of RRM1 and BRCA1"}, {"pubmed": 21424698, "text": "The RRM1 2464 A/G, RRM1 37 C/C and RRM1 524 T/T alleles were associated with statistically significant superior progression free survival in pancreatic cancer patients receiving combination gemcitabine and sorafenib"}, {"pubmed": 21628579, "text": "Data suggest ribonucleotide reductase A site binding with inhibitor."}, {"pubmed": 21642870, "text": "Single-nucleotide polymorphisms in RRM1 gene is associated with treatment response in non-small cell lung cancer."}, {"pubmed": 22134350, "text": "RRM1 polymorphisms as well as haplotypes showed an association with gemcitabine treatment efficacy and toxicity."}, {"pubmed": 22705007, "text": "RRM1 levels in pancreatic ductal adenocarcinoma did not predict survival times in patients treated with adjuvant gemcitabine."}, {"pubmed": 23086647, "text": "The expression of RRMI and ERCC1 genes in tumor tissues and RRM1 in peripheral blood lymphocytes is closely correlated with the response to chemotherapy and prognosis of patients with advanced non-small cell lung cancer."}, {"pubmed": 23155271, "text": "We assessed the relation of mRNA levels of ERCC1, RRM1, and BRCA1 to survival in surgically-resected tumor tissues from patients who underwent adjuvant chemotherapy"}, {"pubmed": 23249808, "text": "Report essential roles for ribonucleotide reductase and thymidylate synthase in C-MYC-dependent suppression of senescence in melanoma cells."}, {"pubmed": 23401439, "text": "RRM1 biomarkers may represent a major step toward biology-based prescription of cytotoxic compounds for lung neoplasms."}, {"pubmed": 23519412, "text": "The X-ray structure of two methylated tandem RRM domains (RRM1/2) of Hu antigen R (HuR) in their RNA-free form has been solved. Protein-RNA interactions designate RRM1 as the primary AU-rich element (ARE)-binding domain in HuR."}, {"pubmed": 23552804, "text": "RR1 expression may discriminate cervical cancer phenotype and radiochemotherapy outcome"}, {"pubmed": 23803067, "text": "High RRM1 expression is associated with non-small cell lung cancer."}, {"pubmed": 23922955, "text": "Ribonucleotide reductase large subunit M1 predicts poor survival due to modulation of proliferative and invasive ability of gastric cancer."}, {"pubmed": 23948418, "text": "The expressions of MDR-1, RRM-1, EGFR, ERCC-1 were observed in a variety of pathological types of NSCLC."}, {"pubmed": 23982437, "text": "The analysis of RRM1 (-37C>A) more than ERCC1 (19007C>T) polymorphism may be a promising tool in the qualification of NSCLC patients for chemotherapy containing platinum compounds and gemcitabine"}, {"pubmed": 23991987, "text": "Low RRM1 expression is associated with response to therapy in pancreatic cancer."}, {"pubmed": 24024897, "text": "These results suggest that SNPs within ribonucleotide reductase (RRM1 and RRM2) might be helpful predictive markers of response to nucleoside analogs and should be further validated in larger cohorts."}, {"pubmed": 24045016, "text": "We observed an increase of ORR in NSCLC patients when they were treated with chemotherapy according to ERCC1 and RRM1 SNPs status."}, {"pubmed": 24155212, "text": "low expression of RRM1 and RRM2 could be used to predict the treatment response to platinum-based chemotherapy and survival in non-small cell lung cancer"}, {"pubmed": 24215511, "text": "we found no support of the hypothesis that aberrations of RRM1 or RRM2B, neither individually nor in combination, are associated with an altered clinical outcome following chemotherapy."}, {"pubmed": 24266856, "text": "No change in RRM1 expression was observed in primary NSCLC tumours, but expression seemed to be higher in N2 lymph node metastases following chemotherapy."}, {"pubmed": 24361227, "text": "Genetic polymorphisms in SLC28A3, SLC29A1 and RRM1 can influence the clinical outcome of metastatic breast cancer patients treated with paclitaxel-gemcitabine chemotherapy."}, {"pubmed": 24434653, "text": "RRM1 preserves chromosomal stability via the CHK1- and CDK1-dependent stabilization of the centrosomal integrity at the replication stage."}, {"pubmed": 24578158, "text": "Gene polymorphisms of RRM1 -756T>C and RRM1 -269C>A may be not an important factor for the susceptibility of breast cancer."}, {"pubmed": 24591771, "text": "RRM1 gene expression may contribute to chemotherapy sensitivity and may be an indicator of survival in nonsmall cell lung cancer patients treated with gemcitabine plus cisplatin."}, {"pubmed": 24595080, "text": "RRM1 IHC expression tailored selection of first-line therapy could improve therapeutic outcomes in patients with advanced NSCLC."}, {"pubmed": 24614341, "text": "Bmi1 and possibly RNF2 may be attractive biomarkers of gemcitabine resistance in the context of RRM1 expression."}, {"pubmed": 24861915, "text": "In Turkish population RRM1 rs12806698 carriers have nearly twofold risk for development of head and neck squamous epithelial cell cancer."}, {"pubmed": 25032731, "text": "High intratumoural hENT1 and low RRM1 expression were independently associated with prolonged disease-free survival in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy."}, {"pubmed": 25078585, "text": "Patients with high RRM1 expression benefited more from a platinum-containing regimen, and patients with high BRCA1 expression showed a high response rate to a platinum-containing regimen and reduced disease progression."}, {"pubmed": 25227663, "text": "concomitant low expression levels of ERCC1, RRM1, and RRM2 and the high expression level of BRCA1 were predictive of a better outcome."}, {"pubmed": 25256246, "text": "The oligomerization-directed fluorescence quenching of hRNR-alpha, covalently labeled with two fluorophores, allows for direct readout of hRNR dimeric and hexameric states."}, {"pubmed": 25497672, "text": "Data demonstrate that RRM1 gene interferes with mitotane metabolism in adrenocortical cancer cells, as a possible mechanisms of drug resistance."}, {"pubmed": 25560468, "text": "These in vitro results suggest that mRNA expression levels of the RRM1 and ABCB1 genes may be useful indicators of chemosensitivity to gemcitabine and cisplatin."}, {"pubmed": 25638032, "text": "we propose that RRM1 protein can inhibit CRC invasion and metastasis at the advanced stage by regulating PTEN transactivation and its downstream pathways in addition to forming an RR holoenzyme for supporting cancer proliferation."}, {"pubmed": 25837929, "text": "It is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells."}, {"pubmed": 25840756, "text": "RRM1 expression was identified as independent prognosticators for freedom from recurrence of malignant pleural mesothelioma in patients undergoing induction chemotherapy followed by extrapleural pneumonectomy."}, {"pubmed": 26028097, "text": "For RRM1 C37A-T524C genotype, sensitive group had higher proportion of high effective genotype than non-sensitive group (p=0.009)."}, {"pubmed": 26083014, "text": "RNA expression of deoxycytidine kinase (DCK), human equilibrative nucleoside transporter-1 (ENT1) and ribonucleotide reductase M1 (RRM1) were significantly higher and cytidine deaminase (CDA) was significantly lower in ex vivo Ara-C sensitive samples."}, {"pubmed": 26200905, "text": "RRM1 expression was predictive and prognostic of clinical outcome in advanced UC treated with gemcitabine plus platinum combination chemotherapy"}, {"pubmed": 26252353, "text": "TUBB3, TOP2A, CYP19A1 and CYP2D6 gene expression, but not protein expression, was associated with patient survival."}, {"pubmed": 26254808, "text": "Adenoviral vector expressing short hairpin RNA targeting RRM1 exerts potent antitumor effects and increases sensitivity to gemcitabine."}, {"pubmed": 26323924, "text": "The genotype of ribonucleotidereductase M1 -269C > A is associated with the response to platinum-based chemotherapy and as a prognostic biomarker in advanced nonsmall cell lung cancer"}, {"pubmed": 26542178, "text": "study finds that ERCC1 and RRM1 are not independent prognostic factors of recurrence in stage I non-small cell lung cancer patients"}, {"pubmed": 26612755, "text": "RRM1 and ERCC1 expression levels did not show any relationship with overall survival."}, {"pubmed": 26637889, "text": "A possible predictive impact of ribonucleotide-reductase subunit-1 (RRM1) on vinorelbine efficacy in non-small cell lung cancer (NSCLC) has been previously reported."}, {"pubmed": 26650486, "text": "Presence of rare AA (-37C>A) and CC (-524C>T) genotypes of the RRM1 may be favorable predictive factors for chemotherapy with platinum compounds and gemcitabine in non-small cell lung cancer patients."}, {"pubmed": 26718430, "text": "A significant association has been found between RRM1 rs12806698 (-269C>A) RRM1 genotype and the risk for developing non-small cell lung cancer."}, {"pubmed": 26828016, "text": "Results underline the relevance of microRNA-101-3p-driven regulation of RRM1 in pancreatic ductal carcinoma gemcitabine resistance."}, {"pubmed": 27173327, "text": "mRNA expression of RRM1 was closely associated with cell proliferation and varied in seven non-Hodgkin lymphoma cell lines."}, {"pubmed": 27179014, "text": "The genetic polymorphisms RRM1 -756T>C and -269C>A may not be a factor for susceptibility to cervical neoplasia"}, {"pubmed": 27566080, "text": "RRM1 and ERCC wild type alleles are risk-reducing factor for Coronary artery disease (CAD). Also, carrying RRM1 A allele might have a protective effect for smokers."}, {"pubmed": 27587543, "text": "three SNPs (corepressor interacting with RBPJ 1 (CIR1) rs13009079T>C, ribonucleotide reductase M1 (RRM1) rs1465952T>C and solute carrier family 38, member 4 (SLC38A4) rs2429467C>T), may play a role in the pathogenesis of lung cancer"}, {"pubmed": 27908619, "text": "RRM1 single nucleotide polymorphism is associated with Non-Small-Cell Lung Cancer."}, {"pubmed": 28066957, "text": "overexpression of RRM1 was correlated with poor prognosis in metastatic bladder cancer patients who underwent gemcitabine-containing chemotherapy"}, {"pubmed": 28411237, "text": "findings suggest that the up-regulated RRM1 and hTrx1 in colorectal cancer directly interact with each other and promote RR activity, resulting in enhanced DNA synthesis and cancer malignancy."}, {"pubmed": 28416140, "text": "RRM1/RRM2B enzyme is capable of retaining activity in hypoxia and therefore is favored over RRM1/RRM2 in order to preserve ongoing replication and avoid the accumulation of DNA damage in hypoxic cells."}, {"pubmed": 28442502, "text": "Our results therefore demonstrate that RRM1 is a novel therapeutic target in multiple myeloma in the preclinical setting and provide the basis for clinical evaluation of RRM1 inhibitor, alone or in combination with DNA-damaging agents, to improve patient outcome in multiple myeloma"}, {"pubmed": 28507282, "text": "TP53 mutant cancer cells had elevation of ribonucleotide reductase subunit 1 (RRM1) and 2 (RRM2), which was reduced by inhibition of mTORC1."}, {"pubmed": 28624910, "text": "Based on the results of clinical trials, we conclude that Ribonucleotide reductase (RR) enzymes (RR1 and RR2)inhibitors are viable treatment options, either as a monotherapy or as a combination in cancer chemotherapy. With the recent advances made in cancer biology, further development of RR inhibitors with improved efficacy and reduced toxicity is possible for treatment of variety of cancers."}, {"pubmed": 29214667, "text": "The expression of RRM1 can be considered a predictor of poor survival in patients with pancreatic cancer receiving gemcitabine chemotherapy."}, {"pubmed": 29865035, "text": "The evaluation of RRM1 gene expression in cfRNA allows for estimation of the risk of severe oral mucositis (OM) in patients subjected to radiotherapy"}, {"pubmed": 30150681, "text": "Nuclear RNR-alpha antagonizes cell proliferation by directly inhibiting ZRANB3"}, {"pubmed": 30458017, "text": "Adenocarcinoma-specific mRNA expression levels of EZH2 and RRM1 are associated with poor post-surgical survival in the first set of patients, but not replicated in a clinically and pathologically matched independent validation set. This study highlights challenges associated with clinical translation of prognostic biomarkers."}, {"pubmed": 31340801, "text": "RRM1 expression was associated with lower relapse rates in non-muscle-invasive bladder cancer patients."}, {"pubmed": 31822713, "text": "WGS-based telomere length analysis in Dutch family trios implicates stronger maternal inheritance and a role for RRM1 gene."}, {"pubmed": 32324262, "text": "LINC02535 co-functions with PCBP2 to regulate DNA damage repair in cervical cancer by stabilizing RRM1 mRNA."}, {"pubmed": 32712628, "text": "Cell-cycle-dependent phosphorylation of RRM1 ensures efficient DNA replication and regulates cancer vulnerability to ATR inhibition."}, {"pubmed": 32842027, "text": "Double-staining Immunohistochemistry Reveals in Malignant Pleural Mesothelioma the Coexpression of ERCC1 and RRM1 as a Frequent Biological Event Related to Poorer Survival."}, {"pubmed": 33921102, "text": "Knockdown of RRM1 with Adenoviral shRNA Vectors to Inhibit Tumor Cell Viability and Increase Chemotherapeutic Sensitivity to Gemcitabine in Bladder Cancer Cells."}, {"pubmed": 34111175, "text": "Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells."}, {"pubmed": 34135160, "text": "Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma."}, {"pubmed": 34353292, "text": "RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin."}, {"pubmed": 34921012, "text": "Targeting Ribonucleotide Reductase Induces Synthetic Lethality in PP2A-Deficient Uterine Serous Carcinoma."}, {"pubmed": 36866763, "text": "RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer."}, {"pubmed": 38040978, "text": "Prognostic value of RRM1 and its effect on chemoresistance in pancreatic cancer."}], "genomic_pos": {"chr": "11", "end": 4138932, "ensemblgene": "ENSG00000167325", "start": 4094707, "strand": 1}, "genomic_pos_hg19": {"chr": "11", "end": 4160106, "start": 4115937, "strand": 1}, "go": {"BP": [{"evidence": "NAS", "gocategory": "BP", "id": "GO:0000731", "pubmed": 10716435, "qualifier": "involved_in", "term": "DNA synthesis involved in DNA repair"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006206", "qualifier": "involved_in", "term": "pyrimidine nucleobase metabolic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006264", "pubmed": 17486094, "qualifier": "involved_in", "term": "mitochondrial DNA replication"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006281", "pubmed": 11719458, "qualifier": "involved_in", "term": "DNA repair"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008584", "qualifier": "involved_in", "term": "male gonad development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0009185", "pubmed": 16376858, "qualifier": "involved_in", "term": "ribonucleoside diphosphate metabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0009263", "qualifier": "involved_in", "term": "deoxyribonucleotide biosynthetic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0009263", "qualifier": "involved_in", "term": "deoxyribonucleotide biosynthetic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0009265", "pubmed": 16376858, "qualifier": "involved_in", "term": "2'-deoxyribonucleotide biosynthetic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010212", "qualifier": "involved_in", "term": "response to ionizing radiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010971", "pubmed": 10716435, "qualifier": "involved_in", "term": "positive regulation of G2/M transition of mitotic cell cycle"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021846", "qualifier": "involved_in", "term": "cell proliferation in forebrain"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051290", "qualifier": "involved_in", "term": "protein heterotetramerization"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060041", "qualifier": "involved_in", "term": "retina development in camera-type eye"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0070318", "pubmed": 11517226, "qualifier": "involved_in", "term": "positive regulation of G0 to G1 transition"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1900087", "pubmed": 24253041, "qualifier": "involved_in", "term": "positive regulation of G1/S transition of mitotic cell cycle"}], "CC": [{"evidence": "IEA", "gocategory": "CC", "id": "GO:0005635", "qualifier": "located_in", "term": "nuclear envelope"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005739", "qualifier": "located_in", "term": "mitochondrion"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "pubmed": 18997010, "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005971", "qualifier": "part_of", "term": "ribonucleoside-diphosphate reductase complex"}, {"evidence": "IPI", "gocategory": "CC", "id": "GO:0005971", "pubmed": 22632967, "qualifier": "part_of", "term": "ribonucleoside-diphosphate reductase complex"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005971", "qualifier": "part_of", "term": "ribonucleoside-diphosphate reductase complex"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0042995", "qualifier": "located_in", "term": "cell projection"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0043025", "qualifier": "located_in", "term": "neuronal cell body"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0004748", "qualifier": "enables", "term": "ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor"}, {"category": "MF", "evidence": "ISS", "id": "GO:0004748", "qualifier": "enables", "term": "ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [17726094, 21336276, 22632967, 28514442, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0005524", "qualifier": "enables", "term": "ATP binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": [17726094, 21336276, 25416956], "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0061731", "pubmed": 21336276, "qualifier": "enables", "term": "ribonucleoside-diphosphate reductase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0097718", "qualifier": "enables", "term": "disordered domain specific binding"}]}, "homologene": {"genes": [[3702, 816715], [4530, 4340258], [4896, 2541695], [4932, 854744], [4932, 856801], [5141, 3872956], [6239, 176301], [7165, 1279619], [7227, 34392], [7955, 30740], [8364, 100145720], [9031, 419081], [9544, 717990], [9598, 450974], [9606, 6240], [9615, 476823], [9913, 505537], [10090, 20133], [10116, 685579], [28985, 2892088], [33169, 4620181], [318829, 2685173]], "id": 806}, "interpro": [{"desc": "Ribonucleotide reductase large subunit, C-terminal", "id": "IPR000788", "short_desc": "RNR_lg_C"}, {"desc": "Ribonucleotide reductase, class I, alpha subunit, C-terminal", "id": "IPR013346", "short_desc": "NrdE_NrdA_C"}, {"desc": "Ribonucleoside-diphosphate reductase large subunit", "id": "IPR039718", "short_desc": "Rrm1"}, {"desc": "ATP-cone domain", "id": "IPR005144", "short_desc": "ATP-cone_dom"}, {"desc": "Ribonucleotide reductase R1 subunit, N-terminal", "id": "IPR008926", "short_desc": "RNR_R1-su_N"}, {"desc": "Ribonucleotide reductase large subunit, N-terminal", "id": "IPR013509", "short_desc": "RNR_lsu_N"}], "ipi": ["IPI00013871", "IPI00943207", "IPI00976088", "IPI00979327", "IPI00979995", "IPI01008934", "IPI01016072"], "map_location": "11p15.4", "name": "ribonucleotide reductase catalytic subunit M1", "other_names": ["ribonucleoside-diphosphate reductase large subunit", "ribonucleoside-diphosphate reductase subunit M1", "ribonucleotide reductase M1 polypeptide", "ribonucleotide reductase, R1 subunit"], "pantherdb": {"HGNC": "10451", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "98180", "ortholog_type": "LDO", "panther_family": "PTHR11573", "taxid": 10090, "uniprot_kb": "P07742"}, {"RGD": "1592569", "ortholog_type": "LDO", "panther_family": "PTHR11573", "taxid": 10116, "uniprot_kb": "Q5U2Q5"}, {"ZFIN": "ZDB-GENE-990415-247", "ortholog_type": "LDO", "panther_family": "PTHR11573", "taxid": 7955, "uniprot_kb": "P79732"}, {"WormBase": "WBGene00004391", "ortholog_type": "LDO", "panther_family": "PTHR11573", "taxid": 6239, "uniprot_kb": "Q03604"}, {"FlyBase": "FBgn0011703", "ortholog_type": "LDO", "panther_family": "PTHR11573", "taxid": 7227, "uniprot_kb": "P48591"}, {"SGD": "S000001328", "ortholog_type": "O", "panther_family": "PTHR11573", "taxid": 4932, "uniprot_kb": "P21672"}, {"SGD": "S000000872", "ortholog_type": "LDO", "panther_family": "PTHR11573", "taxid": 4932, "uniprot_kb": "P21524"}, {"PomBase": "SPAC1F7.05", "ortholog_type": "LDO", "panther_family": "PTHR11573", "taxid": 4896, "uniprot_kb": "P36602"}, {"dictyBase": "DDB_G0284071", "ortholog_type": "LDO", "panther_family": "PTHR11573", "taxid": 352472, "uniprot_kb": "Q54Q71"}, {"TAIR": "2052469", "ortholog_type": "LDO", "panther_family": "PTHR11573", "taxid": 3702, "uniprot_kb": "Q9SJ20"}, {"EnsemblGenome": "BAA16539", "ortholog_type": "O", "panther_family": "PTHR11573", "taxid": 562, "uniprot_kb": "P39452"}, {"EnsemblGenome": "BAA16053", "ortholog_type": "LDO", "panther_family": "PTHR11573", "taxid": 562, "uniprot_kb": "P00452"}], "uniprot_kb": "P23921"}, "pathway": {"humancyc": [{"id": "PWY-7184", "name": "pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis"}, {"id": "PWY-7210", "name": "pyrimidine deoxyribonucleotides biosynthesis from CTP"}, {"id": "PWY-7211", "name": "superpathway of pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis"}, {"id": "PWY-7226", "name": "guanosine deoxyribonucleotides <i>de novo</i> biosynthesis"}, {"id": "PWY-7227", "name": "adenosine deoxyribonucleotides <i>de novo</i> biosynthesis"}, {"id": "PWY-7228", "name": "guanosine nucleotides <i>de novo</i> biosynthesis"}, {"id": "PWY-841", "name": "purine nucleotides <i>de novo</i> biosynthesis"}, {"id": "PWY66-409", "name": "superpathway of purine nucleotide salvage"}], "kegg": [{"id": "hsa00230", "name": "Purine metabolism - Homo sapiens (human)"}, {"id": "hsa00240", "name": "Pyrimidine metabolism - Homo sapiens (human)"}, {"id": "hsa00480", "name": "Glutathione metabolism - Homo sapiens (human)"}, {"id": "hsa00983", "name": "Drug metabolism - other enzymes - Homo sapiens (human)"}], "pid": {"id": "e2f_pathway", "name": "E2F transcription factor network"}, "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-15869", "name": "Metabolism of nucleotides"}, {"id": "R-HSA-499943", "name": "Interconversion of nucleotide di- and triphosphates"}], "smpdb": [{"id": "SMP00050", "name": "Purine Metabolism"}, {"id": "SMP00144", "name": "Adenosine Deaminase Deficiency"}, {"id": "SMP00167", "name": "Adenylosuccinate Lyase Deficiency"}, {"id": "SMP00168", "name": "AICA-Ribosiduria"}, {"id": "SMP00203", "name": "Molybdenum Cofactor Deficiency"}, {"id": "SMP00210", "name": "Purine Nucleoside Phosphorylase Deficiency"}, {"id": "SMP00220", "name": "Xanthine Dehydrogenase Deficiency (Xanthinuria)"}, {"id": "SMP00364", "name": "Lesch-Nyhan Syndrome (LNS)"}, {"id": "SMP00365", "name": "Gout or Kelley-Seegmiller Syndrome"}, {"id": "SMP00427", "name": "Azathioprine Action Pathway"}, {"id": "SMP00428", "name": "Mercaptopurine Action Pathway"}, {"id": "SMP00430", "name": "Thioguanine Action Pathway"}, {"id": "SMP00446", "name": "Gemcitabine Action Pathway"}, {"id": "SMP00512", "name": "Xanthinuria type I"}, {"id": "SMP00513", "name": "Xanthinuria type II"}, {"id": "SMP00535", "name": "Adenine phosphoribosyltransferase deficiency (APRT)"}, {"id": "SMP00536", "name": "Mitochondrial DNA depletion syndrome"}, {"id": "SMP00537", "name": "Myoadenylate deaminase deficiency"}, {"id": "SMP00603", "name": "Gemcitabine Metabolism Pathway"}], "wikipathways": [{"id": "WP1601", "name": "Fluoropyrimidine Activity"}, {"id": "WP2446", "name": "Retinoblastoma gene in cancer"}, {"id": "WP4022", "name": "Pyrimidine metabolism"}, {"id": "WP404", "name": "Nucleotide metabolism"}]}, "pdb": ["2WGH", "3HNC", "3HND", "3HNE", "3HNF", "4X3V", "5D1Y", "5TUS", "6AUI", "6L3R", "6L7L", "6LKM"], "pfam": ["PF00317", "PF02867", "PF03477"], "pharmgkb": "PA298", "pharos": {"target_id": 14030, "tdl": "Tclin"}, "pir": "S16680", "prosite": ["PS51257", "PS51161"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF255891", "relationship": "is"}, {"id": "GNF255892", "relationship": "is"}, {"id": "GNF255893", "relationship": "is"}, {"id": "GNF255894", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF158959", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF034329", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF089501", "relationship": "is"}, {"id": "GNF089502", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF055206", "relationship": "is"}, {"id": "GNF073615", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF062423", "relationship": "is"}, {"id": "GNF062424", "relationship": "is"}], "GNF_hs_LentiORF-HA-MYC": {"id": "GNF282625", "relationship": "is"}, "GNF_hs_LentiORF-Jred": {"id": "GNF283552", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF012892", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF095194", "relationship": "is"}, {"id": "GNF134851", "relationship": "similar to"}]}, "refseq": {"genomic": ["NC_000011.10", "NC_060935.1", "NG_027992.2"], "protein": ["NP_001024.1", "NP_001304993.1", "NP_001304994.1", "NP_001317122.1"], "rna": ["NM_001033.5", "NM_001318064.1", "NM_001318065.1", "NM_001330193.1"], "translation": [{"protein": "NP_001304993.1", "rna": "NM_001318064.1"}, {"protein": "NP_001317122.1", "rna": "NM_001330193.1"}, {"protein": "NP_001304994.1", "rna": "NM_001318065.1"}, {"protein": "NP_001024.1", "rna": "NM_001033.5"}]}, "reporter": {"HG-U133_Plus_2": ["201476_s_at", "201477_s_at"], "HG-U95Av2": "34314_at", "HTA-2_0": "TC11000090.hg.1", "HuEx-1_0": "3318009", "HuGene-1_1": "7937915", "HuGene-2_1": "16721126"}, "retired": 143509, "summary": "This gene encodes the large and catalytic subunit of ribonucleotide reductase, an enzyme essential for the conversion of ribonucleotides into deoxyribonucleotides. A pool of available deoxyribonucleotides is important for DNA replication during S phase of the cell cycle as well as multiple DNA repair processes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015].", "symbol": "RRM1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1335648"}, "unigene": "Hs.445705", "uniprot": {"Swiss-Prot": "P23921", "TrEMBL": ["B4DXD1", "E9PL69", "B4E0I8", "E9PRY9", "E9PJ62", "H0YCY7", "E9PP77"]}, "wikipedia": {"url_stub": "RRM1"}}